Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 265-276 of 12,112
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

This study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

Multiple locations, including Homewood
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

Multiple locations, including Chandler
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Other study type icon
RecruitingNCT06540833

ITI-1284 for Schizophrenia

This study is recruiting in the United States, in Bulgaria, in Croatia, .... It is testing ITI-1284 for Schizophrenia.

Multiple locations, including Anaheim
SchizophreniaOtherOver 55 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Other study type icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.

Multiple locations, including Phoenix
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Other study type icon
RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression.

Multiple locations, including Tucson
DepressionOtherFrom 18 Years to 65 Years
Countries
United States, Australia, Canada, ...
Sponsor
atai Therapeutics, Inc.
Condition
Depression
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.

Multiple locations, including Glendale
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

This study is recruiting in the United States, in France, in Belgium, .... It is testing KarXT for Schizophrenia.

Multiple locations, including Chandler
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.

Multiple locations, including Gilbert
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, Australia, Canada, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.